DexCom , Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) systems for diabetes management with a market capitalization of $34.8 billion, finds itself at a critical juncture as ...

Medical device company DexCom (NASDAQ:DXCM) announced better-than-expected revenue in Q1 CY2025, with sales up 12.5% year on year to $1.04 billion. The company expects the full year’s revenue to ...

Medical device company DexCom (NASDAQ:DXCM) will be reporting earnings tomorrow after the bell. Here’s what investors should know.

Shares of DexCom Inc. tumbled more than 40% on Friday and were headed for their worst percentage drop on record, a day after the maker of diabetes-management equipment shocked investors with a cut ...

Dexcom starts selling its new over-the-counter glucose monitor. Here’s how much it costs The San Diego company launched the first FDA-approved continuous glucose monitor that doesn't require a ...

(COLORADO SPRINGS) — FOX21 News has learned alternative ways people are getting around the shortage of the medical device called the Dexcom, a glucose monitor for diabetes. Some diabetics are ...

DexCom DXCM -2.45% and Abbott Diabetes Care entered a settlement and patent cross-license agreement, resolving all outstanding litigation between the companies. The companies have been involved in ...

ŌURA has just announced a partnership with Dexcom that will allow the Oura Ring to help monitor your blood sugar.

Garmin has announced the release of a blood glucose monitoring app for its watches, those with access to the Garmin Connect app store It’s the Dexcom app, which hints at the the limits of tech here.

Is DexCom stock a buy on the sell-off? With DexCom's massive decline today, you'd think the sky was falling for the company. That doesn't appear to be the case.

Medical device maker Dexcom beat Wall Street estimates for third-quarter revenue and profit on Thursday, helped by resilient demand for its continuous glucose monitors for diabetes patients and ...